Huang Zhe, Wang Ming, Chen Yitian, Tang Hua, Tang Kuo, Zhao Mingkuan, Yang Wei, Zhou Zhengjun, Tian Junjie, Xiang Wei, Li Shenjie, Luo Qinglian, Liu Luotong, Zhao Yanru, Li Tao, Zhou Jie, Chen Ligang
Department of Neurosurgery, The Affiliated Hospital, Southwest Medical University, Luzhou, 646000, PR China.
Sichuan Clinical Medical Research Center for Neurosurgery, Luzhou, 646000, PR China.
Commun Biol. 2025 Jan 20;8(1):91. doi: 10.1038/s42003-025-07526-w.
Almost all high-grade gliomas, particularly glioblastoma (GBM), are highly migratory and aggressive. Migrasomes are organelles produced by highly migratory cells capable of mediating intercellular communication. Thus, GBM cells may produce migrasomes during migration. However, it remains unclear whether migrasomes can influence GBM migration and invasion. In this study, we observed the presence and formation of migrasomes in GBM cells. We found that expression levels of key migrasome formation factor, tetraspanin 4 (TSPAN4), correlated positively with pathological grade and poor prognosis of GBM based on the databases and clinical samples analysis. Subsequently, we knocked down TSPAN4 and found that GBM cell migration and invasion were significantly inhibited due to the reduced formation of migrasomes. We further confirmed that migrasomes are enriched in extracellular matrix (ECM)-related proteins such as p21-activating kinase 4 (PAK4) and laminin alpha 4 (LAMA4). Our experimental results suggest that migrasomes promote GBM cells migration by releasing such proteins into the extracellular space. Overall, we identified migrasomes in GBM and the molecular mechanisms by which they regulate them, providing potential targets for treating GBM.
几乎所有的高级别胶质瘤,尤其是胶质母细胞瘤(GBM),都具有高度的迁移性和侵袭性。迁移小体是由具有高度迁移能力的细胞产生的细胞器,能够介导细胞间通讯。因此,GBM细胞在迁移过程中可能会产生迁移小体。然而,迁移小体是否能影响GBM的迁移和侵袭仍不清楚。在本研究中,我们观察了GBM细胞中迁移小体的存在和形成。基于数据库和临床样本分析,我们发现关键的迁移小体形成因子四跨膜蛋白4(TSPAN4)的表达水平与GBM的病理分级和不良预后呈正相关。随后,我们敲低了TSPAN4,发现由于迁移小体形成减少,GBM细胞的迁移和侵袭受到显著抑制。我们进一步证实,迁移小体富含细胞外基质(ECM)相关蛋白,如p21激活激酶4(PAK4)和层粘连蛋白α4(LAMA4)。我们的实验结果表明,迁移小体通过将此类蛋白释放到细胞外空间来促进GBM细胞迁移。总体而言,我们在GBM中鉴定出了迁移小体及其调控机制,为治疗GBM提供了潜在靶点。